Search for dissertations about: "Cardiac statins"
Showing result 1 - 5 of 16 swedish dissertations containing the words Cardiac statins.
-
1. Patient stratification and treatment effects in diseases with disturbed cardiac function
Abstract : Background: Cardiovascular disease characteristics are often measured using a combination of different measurement modalities. By combining information from these modalities using statistical modelling we can gain additional knowledge about these diseases. READ MORE
-
2. On secondary prevention after acute coronary syndrome : -what, when, and who
Abstract : BackgroundCardiovascular disease, of which coronary heart disease constitutes the lion’s share, is the leading cause of premature morbidity and mortality worldwide. Management of the condition has evolved rapidly in recent decades, and mortality has more than halved in the western world. READ MORE
-
3. Cardiovascular Risk Genes in Prevention and Treatment Response
Abstract : GENERAL AIM: To investigate how common single-nucleotide-polymorphisms (SNPs) that associate with cardiovascular disease (CVD) could be used in prevention and treatment of CVD. SUBJECTS: Subjects from the population-based Malmö-Diet-and-Cancer-(MDC)-Study (n=30447) and hypertensives from the Nordic-Diltiazem-(NORDIL)-Study (n=10881). READ MORE
-
4. Platelet inhibition and secondary prevention in cardiac surgery patients
Abstract : ABSTRACT Background and objective Coronary artery bypass grafting (CABG) is the most common cardiac surgery procedure. Dual antiplatelet therapy (DAPT) reduces the risk for ischaemic events in patients with acute coronary syndrome (ACS) but increases the bleeding risk, both for spontaneous bleedings and procedure-related bleedings for the subset of ACS patients undergoing urgent CABG. READ MORE
-
5. Analysis of risk factors in patients with severe chronic kidney disease. The role of atorvastatin
Abstract : Background and aim: There had been no randomized end-point studies with statins for patients with severe renal failure. The purpose of this prospective, open, randomized, controlled study was to investigate whether atorvastatin (10 mg/day) would alter cardiovascular end-points and the overall mortality rate of patients with chronic kidney disease stage 4 or 5 (creatinine clearanceMaterial & Methods: This was an open, prospective, randomized study. READ MORE